Vasohibin-1 and retinal pigment epithelium

Adv Exp Med Biol. 2012:723:305-10. doi: 10.1007/978-1-4614-0631-0_40.

Authors

Yumi Ishikawa¹, Nobuhiro Nagai, Hideyuki Onami, Norihiro Kumasaka, Ryosuke Wakusawa, Hikaru Sonoda, Yasufumi Sato, Toshiaki Abe

Affiliation

¹ Division of Clinical Cell Therapy, United Center for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 1-1 Seiryoumachi Aobaku Sendai, Miyagi, Japan.

PMID: 22183347
DOI: 10.1007/978-1-4614-0631-0_40

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antimutagenic Agents / pharmacology
Cell Cycle Proteins / genetics*
Cell Cycle Proteins / metabolism
Cell Cycle Proteins / pharmacology*
Cell Line
Choroidal Neovascularization / drug therapy*
Choroidal Neovascularization / genetics
Choroidal Neovascularization / pathology
Cobalt / pharmacology
DNA, Complementary / pharmacology
Gene Expression / physiology
Genetic Therapy / methods
Humans
Hypoxia / drug therapy
Hypoxia / genetics
Hypoxia / pathology
Rats
Retinal Pigment Epithelium / cytology
Retinal Pigment Epithelium / drug effects*
Retinal Pigment Epithelium / physiology*
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Vascular Endothelial Growth Factor A / metabolism

Substances

Antimutagenic Agents
Cell Cycle Proteins
DNA, Complementary
VASH1 protein, human
VEGFA protein, human
Vascular Endothelial Growth Factor A
Cobalt
cobaltous chloride